Biomerica, Inc.
BMRA
$3.88
$0.123.19%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.16M | -950.00K | -1.32M | -1.42M | -1.92M |
| Total Depreciation and Amortization | 99.00K | 100.00K | 97.00K | 97.00K | 94.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 72.00K | 148.00K | 94.00K | 176.00K | 335.00K |
| Change in Net Operating Assets | -53.00K | -89.00K | -219.00K | 104.00K | -312.00K |
| Cash from Operations | -1.05M | -791.00K | -1.34M | -1.04M | -1.80M |
| Capital Expenditure | -- | -- | -- | -24.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.00K | -33.00K | -- | 0.00 | -16.00K |
| Cash from Investing | -4.00K | -33.00K | -- | -24.00K | -16.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.77M | 392.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -31.00K | -12.00K | -- | -81.00K | -- |
| Cash from Financing | 1.74M | 380.00K | -- | -81.00K | -- |
| Foreign Exchange rate Adjustments | -1.00K | -4.00K | -6.00K | 0.00 | 2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 686.00K | -448.00K | -1.35M | -1.15M | -1.82M |